跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METOPROLOL TARTRATE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
METOPROLOL TARTRATE INJECTION USP
Authorized
STANDARD
METOPROLOL TARTRATE INJECTION USP
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f196607ae8a19290
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
f196607ae8a19290
Drug Approval Canada Name
METOPROLOL TARTRATE INJECTION USP
Product Name
METOPROLOL TARTRATE INJECTION USP
Status
Marketed
Status Date
2021-07-27
Original Market Date
2019-07-08
Din
02474271
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
24:24.00
Atc Original
C07AB02 METOPROLOL
Atc Name
c 07 ab 02
Aig Number
0111923004
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
METOPROLOL TARTRATE
1 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f196607ae8a19290
Type
Standard
Back to Health Canada Approvals